| Jennifer Denise Shields, | |
|
102 Brickerton St, Columbus, MS 39701-3608 | |
| (662) 570-1109 | |
| Not Available |
| Full Name | Jennifer Denise Shields |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 102 Brickerton St, Columbus, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891551503 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | (* (Not Available)) | Secondary |
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Denise Shields, 102 Brickerton St, Columbus, MS 39701-3608 Ph: (662) 570-1109 | Jennifer Denise Shields, 102 Brickerton St, Columbus, MS 39701-3608 Ph: (662) 570-1109 |
News Archive
Researchers at Moffitt Cancer Center working with colleagues at three other institutions have validated a link between a rare genetic variant and the risk of glioma, the most common and lethal type of brain tumor.
The hepatitis C therapy peginterferon alfa-2b, when given as low-dose maintenance therapy, can prevent disease progression in certain patients who failed previous interferon-based hepatitis C therapies and have advanced liver disease, according to findings from a large, four-year study presented today at the 43rd annual meeting of the European Association for the Study of the Liver (EASL).
Aeterna Zentaris Inc. today announced that an independent Data Safety Monitoring Board has recommended discontinuing the ongoing Phase 3 study comparing the efficacy and safety of perifosine to placebo when combined with bortezomib (Velcade) and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma.
A University of Colorado Cancer Center study published in the journal PLoS ONE shows that bladder and lung cancers are marked by shared differences in the genetics that control the cell cycle.
Patients who received daily humidification of the mouth and throat region beginning from day one of radiation therapy treatment spent nearly 50 percent fewer days in the hospital to manage their side effects, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.
› Verified 1 days ago
Jacquelynn P Miskel, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3600 Bluecutt Rd Ste 201, Columbus, MS 39705 Phone: 662-434-4210 | |
Sharon Bell, MS Counselor Medicare: Not Enrolled in Medicare Practice Location: 1001 Main St, Columbus, MS 39701 Phone: 662-328-9225 Fax: 662-328-4735 | |
John Mcmahon, LCSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 1001 Main St, Columbus, MS 39701 Phone: 662-328-9225 Fax: 662-328-4735 | |
Quintara A Reese, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2623 5th St N, Columbus, MS 39705 Phone: 662-241-7091 | |
Shanta Newby, Counselor Medicare: Not Enrolled in Medicare Practice Location: 428 24th Ave N, Columbus, MS 39705 Phone: 662-241-7097 | |
Akedra Ross, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2623 5th St N, Columbus, MS 39705 Phone: 662-241-7097 | |
Emily Roberts, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1011 Main St, Columbus, MS 39701 Phone: 662-327-7916 |